Dalia N. Toaima
Ain Shams University
7 Papers
26 Citations
Dalia N. Toaima is an academic researcher from Ain Shams University. The author has contributed to research in topics: Type 1 diabetes & Diabetes mellitus. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
A prospective study of the hypothalamic-pituitary-adrenal axis in children with acute lymphoblastic leukemia receiving chemotherapy
Mona A. Salem,Azza A.G. Tantawy,Haba H. El Sedfy,Mohamed A. El Laboudy,Dalia N. Toaima,Nermine H. Mahmoud,Dalia Selim +6 more
TL;DR: Monitoring of cortisol levels and steroid coverage during stress is recommended, and gradual steroid tapering is suggested, as an inevitable consequence of ALL therapy.
19
Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.
TL;DR: Cardiotoxicity occurred early and at low cumulative doses of doxorubicin in children with HD and RVG was more sensitive than echocardiography in detecting early impairment of LV function, and baseline and serial assessment ofLV function by RVG is recommended.
15
Subclinical renal abnormalities in young thalassemia major and intermedia patients and its relation to chelation therapy
TL;DR: Poor chelation is associated with early signs of renal affection in children and adolescents with b-thalassemia major and intermedia and can start earlier in TM patients compared to TI, according to this study.
10
Diabetic Cystopathy in Children and Adolescents with Type 1 Diabetes Mellitus
Mona A. Salem,Safinaz A. El Habashy,Dalia N. Toaima,Hassan S. Shaker,Osama M. A. H. Hetta,Jonair H. A. El Kafy +5 more
TL;DR: Diabetic neuropathy might be strongly related to urodynamic abnormalities particularly the bladder hypercomplianceparticularly the bladderhypercompliance in children and adolescents with Type 1 diabetes mellitus.
High dose intravenous immunoglobulin in Rh and ABO hemolytic disease of Egyptian neonates
TL;DR: Evaluated effectiveness of high dose Intravenous immune globulin (HD-IVIG) in reducing the need for exchange transfusion, duration of phototherapy and hospitalization in neonates with isoimmune hemolytic disease due to Rh or ABO incompatibility found to be effective.